HEADER SIGNALING PROTEIN 04-MAR-14 2MLQ TITLE HUMAN CCR2 MEMBRANE-PROXIMAL C-TERMINAL REGION (PRO-C) IN A FROUNT TITLE 2 BOUND FORM COMPND MOL_ID: 1; COMPND 2 MOLECULE: MCP-1 RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL REGION, UNP RESIDUES 90-105; COMPND 5 SYNONYM: CCR2, CHEMOKINE_(C-C_MOTIF)_RECEPTOR_2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CCR2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PTKK19 KEYWDS CCR2, PRO-C, FROUNT, SIGNALING PROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.ESAKI,S.YOSHINAGA,T.TSUJI,E.TODA,Y.TERASHIMA,T.SAITOH,D.KOHDA, AUTHOR 2 T.KOHNO,M.OSAWA,T.UEDA,I.SHIMADA,K.MATSUSHIMA,H.TERASAWA REVDAT 4 14-JUN-23 2MLQ 1 REMARK REVDAT 3 24-AUG-22 2MLQ 1 JRNL REVDAT 2 29-OCT-14 2MLQ 1 JRNL REVDAT 1 08-OCT-14 2MLQ 0 JRNL AUTH K.ESAKI,S.YOSHINAGA,T.TSUJI,E.TODA,Y.TERASHIMA,T.SAITOH, JRNL AUTH 2 D.KOHDA,T.KOHNO,M.OSAWA,T.UEDA,I.SHIMADA,K.MATSUSHIMA, JRNL AUTH 3 H.TERASAWA JRNL TITL STRUCTURAL BASIS FOR THE BINDING OF THE MEMBRANE-PROXIMAL JRNL TITL 2 C-TERMINAL REGION OF CHEMOKINE RECEPTOR CCR2 WITH THE JRNL TITL 3 CYTOSOLIC REGULATOR FROUNT. JRNL REF FEBS J. V. 281 5552 2014 JRNL REFN ISSN 1742-464X JRNL PMID 25283965 JRNL DOI 10.1111/FEBS.13096 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : GUNTERT, MUMENTHALER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2MLQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-MAR-14. REMARK 100 THE DEPOSITION ID IS D_1000103765. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 283 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 800 UM [U-100% 15N] CCR2_PRO-C REMARK 210 -1, 20 MM SODIUM PHOSPHATE-2, 50 REMARK 210 MM SODIUM CHLORIDE-3, 8 UM REMARK 210 FROUNT-4, 5 % [U-100% 2H] D2O-5, REMARK 210 95 % H2O-6; 800 UM [U-100% 13C; REMARK 210 U-100% 15N] CCR2_PRO-C-7, 20 MM REMARK 210 SODIUM PHOSPHATE-8, 50 MM SODIUM REMARK 210 CHLORIDE-9, 8 UM FROUNT-10, 100 % REMARK 210 [U-100% 2H] D2O-11; 200 UM [U- REMARK 210 100% 13C; U-100% 15N] CCR2_PRO-C- REMARK 210 12, 20 MM SODIUM PHOSPHATE-13, REMARK 210 50 MM SODIUM CHLORIDE-14, 5 % [U- REMARK 210 100% 2H] D2O-15, 95 % H2O-16; REMARK 210 200 UM [U-100% 13C; U-100% 15N] REMARK 210 CCR2_PRO-C-17, 20 MM SODIUM REMARK 210 PHOSPHATE-18, 50 MM SODIUM REMARK 210 CHLORIDE-19, 100 % [U-100% 2H] REMARK 210 D2O-20; 200 UM [U-100% 15N] CCR2_ REMARK 210 PRO-C-21, 20 MM SODIUM PHOSPHATE- REMARK 210 22, 50 MM SODIUM CHLORIDE-23, 5 % REMARK 210 [U-100% 2H] D2O-24, 95 % H2O-25 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 1H-15N NOESY; 3D 1H-13C REMARK 210 NOESY; 3D CBCA(CO)NH; 3D HNCACB; REMARK 210 3D HBHA(CO)NH; 3D HCCH-TOCSY; 2D REMARK 210 1H-15N HSQC; 2D 1H-13C HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 2 118.67 -162.64 REMARK 500 1 HIS A 14 -62.67 -158.68 REMARK 500 2 LYS A 2 30.42 -151.33 REMARK 500 2 ARG A 4 40.11 -98.94 REMARK 500 2 LYS A 13 -55.63 -120.56 REMARK 500 3 HIS A 14 -57.11 -140.05 REMARK 500 4 PHE A 3 23.33 -154.40 REMARK 500 4 ARG A 4 54.81 -98.65 REMARK 500 4 ARG A 12 49.21 -85.50 REMARK 500 4 LYS A 13 44.13 -106.69 REMARK 500 4 HIS A 14 -47.37 -134.82 REMARK 500 5 PHE A 3 -166.16 -116.57 REMARK 500 5 VAL A 9 -40.27 -135.83 REMARK 500 5 LYS A 13 -72.43 -98.02 REMARK 500 6 ARG A 4 54.67 -95.13 REMARK 500 7 PHE A 3 -168.54 50.84 REMARK 500 9 ARG A 4 57.73 -98.08 REMARK 500 10 PHE A 3 -165.53 -61.90 REMARK 500 11 PHE A 3 -168.33 50.66 REMARK 500 11 HIS A 14 -39.53 -165.97 REMARK 500 13 LYS A 2 -37.92 -177.05 REMARK 500 13 PHE A 3 -163.27 51.21 REMARK 500 13 ARG A 5 -41.47 -136.25 REMARK 500 14 LYS A 2 -40.56 -164.80 REMARK 500 14 PHE A 3 -164.51 63.23 REMARK 500 14 ARG A 5 -40.21 -131.64 REMARK 500 14 ARG A 12 37.39 -91.65 REMARK 500 14 LYS A 13 44.44 -92.17 REMARK 500 14 HIS A 14 -63.96 -140.75 REMARK 500 15 HIS A 14 -74.67 -51.86 REMARK 500 16 LYS A 2 31.69 -152.85 REMARK 500 16 ARG A 4 43.39 -99.22 REMARK 500 16 HIS A 14 -72.97 -51.85 REMARK 500 17 ARG A 4 49.01 -92.63 REMARK 500 18 PHE A 3 30.81 -141.88 REMARK 500 18 ARG A 4 57.76 -95.84 REMARK 500 19 ARG A 4 47.87 -96.02 REMARK 500 19 HIS A 14 -74.87 -51.77 REMARK 500 20 ARG A 4 49.10 -89.55 REMARK 500 20 HIS A 14 -54.60 -158.05 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 19829 RELATED DB: BMRB REMARK 900 RELATED ID: 2MLO RELATED DB: PDB DBREF 2MLQ A 1 16 UNP O95950 O95950_HUMAN 90 105 SEQRES 1 A 16 GLU LYS PHE ARG ARG TYR LEU SER VAL PHE PHE ARG LYS SEQRES 2 A 16 HIS ILE THR HELIX 1 1 TYR A 6 PHE A 11 1 6 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1